Now in Private Beta

AI-Powered
Health Economics
Research at Scale

BARD AInalytics enables researchers and pharma professionals to conduct rigorous HEOR studies — cost-effectiveness analyses, budget impact models, PRO analyses, and more — with built-in methodological guardrails and AI-assisted workflows.

Explore Features
ISPOR-Aligned Methods
HIPAA-Ready Architecture
Audit-Trail Reporting
Platform Capabilities

Built for Serious HEOR Research

Purpose-built tools that meet the methodological standards expected by payers, HTA bodies, and peer-reviewed journals — without the manual overhead.

Cost-Effectiveness Analysis

Build Markov cohort and microsimulation models with automated cycle calculations, transition probability estimation, and probabilistic sensitivity analysis (PSA).

Budget Impact Modeling

Project real-world budget impact for payers and health systems with epidemiology-driven prevalence estimates, market uptake curves, and scenario analysis.

PRO & Utility Mapping

Map patient-reported outcomes (EQ-5D, SF-6D, PROMIS) to utility values and automate HRQoL analysis pipelines for clinical trial data.

AI-Assisted Study Design

Our AI co-pilot guides parameter selection, flags methodological inconsistencies, and suggests literature-backed assumptions aligned with ISPOR and NICE guidelines.

Collaborative Workspaces

Invite co-authors, biostatisticians, and medical writers. Role-based access ensures each team member sees only what they need — with full audit trails.

Publication-Ready Reports

Auto-generate structured reports with CHEERS 2022-aligned reporting, exportable model code, and one-click submission packages for HTA dossiers.

Workflow

From Data to Decision in 3 Steps

Designed to match how HEOR teams actually work — not force you into a rigid workflow.

1

Upload & Configure

Import your clinical trial data, RWE datasets, or cost data. BARD validates structure, flags missing values, and auto-suggests model parameters from your inputs.

2

Run & Validate

Execute your economic model with built-in PSA, DSA, and scenario analyses. The AI engine cross-checks outputs against known HEOR benchmarks and highlights anomalies.

3

Export & Submit

Generate CHEERS-compliant reports, downloadable model code (R/Excel), and formatted outputs ready for HTA submissions, ISPOR posters, or peer review.

Study Types

Every HEOR Study Type, Supported

📊
Cost-Utility Analysis
💰
Budget Impact Model
🔬
Network Meta-Analysis
📋
PRO Analysis
🔄
Real-World Evidence
📈
Disease Modeling
⚖️
Risk Sharing Analysis
🧪
Survival Analysis
Security & Compliance

Enterprise-Grade Security for Sensitive Health Data

Health economic data often involves proprietary clinical trial results and patient-level data. BARD AInalytics is designed with HIPAA-readiness, end-to-end encryption, and comprehensive audit logging from the ground up.

AES-256 data encryption at rest
TLS 1.3 in transit
MFA for all accounts
Role-based access control
Complete audit trail logging
SOC 2 Type II (roadmap)
HIPAA-Ready Infrastructure

Business Associate Agreements available for enterprise clients handling PHI.

Zero-Trust Access Model

Every API request is authenticated and authorized. No implicit trust between services.

Immutable Audit Logs

Every model run, parameter change, and data access is logged and tamper-evident.

Limited Beta Spots Available

Join the BARD AInalytics Beta

We're onboarding a small cohort of HEOR researchers and pharma teams to test the platform and shape its roadmap. Accepted beta users get free access during the beta period.

No spam. No credit card required. Unsubscribe anytime.